Dynamic Switch of Negative Feedback Regulation in Akt–TOR Signaling

1. GhiglioneC

CarrawayKL3rd

AmundadottirLT

BoswellRE

PerrimonN

1999 The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis. Cell 96 847 856

2. KleinDE

NappiVM

ReevesGT

ShvartsmanSY

LemmonMA

2004 Argos inhibits epidermal growth factor receptor signalling by ligand sequestration. Nature 430 1040 1044

3. YooAS

BaisC

GreenwaldI

2004 Crosstalk between the EGFR and LIN-12/Notch pathways in C. elegans vulval development. Science 303 663 666

4. PerrimonN

McMahonAP

1999 Negative feedback mechanisms and their roles during pattern formation. Cell 97 13 16

5. FreemanM

2000 Feedback control of intercellular signalling in development. Nature 408 313 319

6. RohatgiR

ScottMP

2007 Patching the gaps in Hedgehog signalling. Nat Cell Biol 9 1005 1009

7. NiehrsC

2006 Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25 7469 7481

8. Pendas-FrancoN

GarciaJM

PenaC

ValleN

PalmerHG

2008 DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene 27 4467 4477

9. DhillonAS

von KriegsheimA

GrindlayJ

KolchW

2007 Phosphatase and feedback regulation of Raf-1 signaling. Cell Cycle 6 3 7

10. KeyseSM

2000 Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12 186 192

11. LoTL

FongCW

YusoffP

McKieAB

ChuaMS

2006 Sprouty and cancer: the first terms report. Cancer Lett 242 141 150

12. MasonJM

MorrisonDJ

BassonMA

LichtJD

2006 Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 16 45 54

13. ValentinoL

PierreJ

2006 JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 71 713 721

14. LetterioJJ

2005 TGF-beta signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene 24 5701 5712

15. CourtoisG

GilmoreTD

2006 Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25 6831 6843

16. SarbassovDD

GuertinDA

AliSM

SabatiniDM

2005 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 1098 1101

17. GuertinDA

SabatiniDM

2007 Defining the role of mTOR in cancer. Cancer Cell 12 9 22

18. ShawRJ

CantleyLC

2006 Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441 424 430

19. PearceLR

HuangX

BoudeauJ

PawlowskiR

WullschlegerS

2007 Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem J 405 513 522

20. ThedieckK

PolakP

KimML

MolleKD

CohenA

2007 PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS ONE 2 e1217 doi:10.1371/journal.pone.0001217

21. CalnanDR

BrunetA

2008 The FoxO code. Oncogene 27 2276 2288

22. InokiK

CorradettiMN

GuanKL

2005 Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37 19 24

23. ManningBD

CantleyLC

2003 Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 28 573 576

24. MontagneJ

StewartMJ

StockerH

HafenE

KozmaSC

1999 Drosophila S6 kinase: a regulator of cell size. Science 285 2126 2129

25. RichardsonCJ

SchalmSS

BlenisJ

2004 PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev Biol 15 147 159

26. JacintoE

FacchinettiV

LiuD

SotoN

WeiS

2006 SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127 125 137

27. GuertinDA

StevensDM

ThoreenCC

BurdsAA

KalaanyNY

2006 Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11 859 871

28. ShiotaC

WooJT

LindnerJ

SheltonKD

MagnusonMA

2006 Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev Cell 11 583 589

29. FriasMA

ThoreenCC

JaffeJD

SchroderW

SculleyT

2006 mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 16 1865 1870

30. ShawRJ

KosmatkaM

BardeesyN

HurleyRL

WittersLA

2004 The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101 3329 3335

31. ShawRJ

BardeesyN

ManningBD

LopezL

KosmatkaM

2004 The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6 91 99

32. InokiK

ZhuT

GuanKL

2003 TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 577 590

33. DannSG

ThomasG

2006 The amino acid sensitive TOR pathway from yeast to mammals. FEBS Lett 580 2821 2829

34. BruggeJ

HungMC

MillsGB

2007 A new mutational AKTivation in the PI3K pathway. Cancer Cell 12 104 107

35. DannSG

SelvarajA

ThomasG

2007 mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13 252 259

36. NiYG

WangN

CaoDJ

SachanN

MorrisDJ

2007 FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci U S A 104 20517 20522

37. NiYG

BerenjiK

WangN

OhM

SachanN

2006 Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 114 1159 1168

38. PuigO

MarrMT

RuhfML

TjianR

2003 Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev 17 2006 2020

39. PuigO

TjianR

2005 Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev 19 2435 2446

40. MarrMT2nd

D'AlessioJA

PuigO

TjianR

2007 IRES-mediated functional coupling of transcription and translation amplifies insulin receptor feedback. Genes Dev 21 175 183

41. ShahOJ

HunterT

2005 Tuberous sclerosis and insulin resistance. Unlikely bedfellows reveal a TORrid affair. Cell Cycle 4 46 51

42. ManningBD

LogsdonMN

LipovskyAI

AbbottD

KwiatkowskiDJ

2005 Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 19 1773 1778

43. HarutaT

UnoT

KawaharaJ

TakanoA

EgawaK

2000 A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol 14 783 794

44. RuiL

FisherTL

ThomasJ

WhiteMF

2001 Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J Biol Chem 276 40362 40367

45. EdgarBA

2006 How flies get their size: genetics meets physiology. Nat Rev Genet 7 907 916

46. WullschlegerS

LoewithR

HallMN

2006 TOR signaling in growth and metabolism. Cell 124 471 484

47. LeeversSJ

aHE

2004 Growth Regulation by Insulin and Tor Signaling in Drosophila.

HallM

Raff

Martin

Thomas

George

Cell Growth: Control of Cell Size New York Cold Spring Harbor Press Laboratory Press

48. HietakangasV

CohenSM

2007 Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth. Genes Dev 21 632 637

49. LeeG

ChungJ

2007 Discrete functions of rictor and raptor in cell growth regulation in Drosophila. Biochem Biophys Res Commun 357 1154 1159

50. YangQ

InokiK

KimE

GuanKL

2006 TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc Natl Acad Sci U S A 103 6811 6816

51. GuertinDA

StevensDM

SaitohM

KinkelS

CrosbyK

2009 mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15 148 159

52. LuoJ

ManningBD

CantleyLC

2003 Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 257 262

53. ManningBD

CantleyLC

2007 AKT/PKB signaling: navigating downstream. Cell 129 1261 1274

54. UmSH

D'AlessioD

ThomasG

2006 Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3 393 402

55. WeinkoveD

NeufeldTP

TwardzikT

WaterfieldMD

LeeversSJ

1999 Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor. Curr Biol 9 1019 1029

56. BohniR

Riesgo-EscovarJ

OldhamS

BrogioloW

StockerH

1999 Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97 865 875

57. GoberdhanDC

ParicioN

GoodmanEC

MlodzikM

WilsonC

1999 Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev 13 3244 3258

58. BrandAH

PerrimonN

1993 Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118 401 415

59. BoutrosM

KigerAA

ArmknechtS

KerrK

HildM

2004 Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 303 832 835

60. HsuYC

ChernJJ

CaiY

LiuM

ChoiKW

2007 Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature 445 785 788

61. RehmannH

BruningM

BerghausC

SchwartenM

KohlerK

2008 Biochemical characterisation of TCTP questions its function as a guanine nucleotide exchange factor for Rheb. FEBS Lett 582 3005 3010

62. WangX

FonsecaBD

TangH

LiuR

EliaA

2008 Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling. J Biol Chem 283 30482 30492

63. KwiatkowskiDJ

2003 Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Cancer Biol Ther 2 471 476

64. PanD

DongJ

ZhangY

GaoX

2004 Tuberous sclerosis complex: from Drosophila to human disease. Trends Cell Biol 14 78 85

65. RadimerskiT

MontagneJ

Hemmings-MieszczakM

ThomasG

2002 Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev 16 2627 2632

66. ShahOJ

WangZ

HunterT

2004 Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14 1650 1656

67. HarringtonLS

FindlayGM

GrayA

TolkachevaT

WigfieldS

2004 The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166 213 223

68. HidalgoM

RowinskyEK

2000 The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19 6680 6686

69. MitaMM

MitaA

RowinskyEK

2003 The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol Ther 2 S169 177

70. SawyersCL

2003 Will mTOR inhibitors make it as cancer drugs? Cancer Cell 4 343 348

71. GaoX

ZhangY

ArrazolaP

HinoO

KobayashiT

2002 Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 4 699 704

72. StaveleyBE

RuelL

JinJ

StambolicV

MastronardiFG

1998 Genetic analysis of protein kinase B (AKT) in Drosophila. Curr Biol 8 599 602

73. WuJS

LuoL

2006 A protocol for mosaic analysis with a repressible cell marker (MARCM) in Drosophila. Nat Protoc 1 2583 2589

74. BlairSS

2003 Genetic mosaic techniques for studying Drosophila development. Development 130 5065 5072

75. PotterCJ

PedrazaLG

XuT

2002 Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4 658 665

76. GaoX

PanD

2001 TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev 15 1383 1392

77. TaponN

ItoN

DicksonBJ

TreismanJE

HariharanIK

2001 The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105 345 355

78. PotterCJ

HuangH

XuT

2001 Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 105 357 368

79. DattaSR

BrunetA

GreenbergME

1999 Cellular survival: a play in three Akts. Genes Dev 13 2905 2927

80. HwangboDS

GershmanB

TuMP

PalmerM

TatarM

2004 Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 429 562 566

81. JungerMA

RintelenF

StockerH

WassermanJD

VeghM

2003 The Drosophila forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J Biol 2 20

82. LongX

LinY

Ortiz-VegaS

YonezawaK

AvruchJ

2005 Rheb Binds and Regulates the mTOR Kinase. Curr Biol 15 702 713

83. LongX

Ortiz-VegaS

LinY

AvruchJ

2005 Rheb binding to mTOR is regulated by amino acid sufficiency. J Biol Chem

84. SaucedoLJ

GaoX

ChiarelliDA

LiL

PanD

2003 Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol 5 566 571

85. StockerH

RadimerskiT

SchindelholzB

WittwerF

BelawatP

2003 Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol 5 559 565

86. BhaskarPT

HayN

2007 The two TORCs and Akt. Dev Cell 12 487 502

87. TremblayF

LavigneC

JacquesH

MaretteA

2007 Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu Rev Nutr 27 293 310

88. DennisPB

PullenN

PearsonRB

KozmaSC

ThomasG

1998 Phosphorylation sites in the autoinhibitory domain participate in p70(s6k) activation loop phosphorylation. J Biol Chem 273 14845 14852

89. DennisPB

PullenN

KozmaSC

ThomasG

1996 The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol Cell Biol 16 6242 6251

90. BarceloH

StewartMJ

2002 Altering Drosophila S6 kinase activity is consistent with a role for S6 kinase in growth. Genesis 34 83 85

91. RadimerskiT

MontagneJ

RintelenF

StockerH

van der KaayJ

2002 dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nat Cell Biol 4 251 255

92. BjedovI

ToivonenJM

KerrF

SlackC

JacobsonJ

2010 Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab 11 35 46

93. MartinKA

MerenickBL

DingM

FetalveroKM

RzucidloEM

2007 Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem 282 36112 36120

94. MaL

Teruya-FeldsteinJ

BehrendtN

ChenZ

NodaT

2005 Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev 19 1779 1786

95. KalaanyNY

SabatiniDM

2009 Tumours with PI3K activation are resistant to dietary restriction. Nature 458 725 731

96. ShahOJ

HunterT

2006 Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis. Mol Cell Biol 26 6425 6434

97. TzatsosA

KandrorKV

2006 Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 26 63 76

98. HayN

2005 The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8 179 183

99. HuangJ

DibbleCC

MatsuzakiM

ManningBD

2008 The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 28 4104 4115

100. VerduJ

BuratovichMA

WilderEL

BirnbaumMJ

1999 Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat Cell Biol 1 500 506

101. SkeenJE

BhaskarPT

ChenCC

ChenWS

PengXD

2006 Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell 10 269 280

102. ManningBD

TeeAR

LogsdonMN

BlenisJ

CantleyLC

2002 Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10 151 162

103. InokiK

LiY

ZhuT

WuJ

GuanKL

2002 TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4 648 657

104. TavazoieSF

AlvarezVA

RidenourDA

KwiatkowskiDJ

SabatiniBL

2005 Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 8 1727 1734

105. DongJ

PanD

2004 Tsc2 is not a critical target of Akt during normal Drosophila development. Genes Dev 18 2479 2484

106. Vander HaarE

LeeSI

BandhakaviS

GriffinTJ

KimDH

2007 Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9 316 323

107. SancakY

ThoreenCC

PetersonTR

LindquistRA

KangSA

2007 PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25 903 915

108. FonsecaBD

SmithEM

LeeVH

MacKintoshC

ProudCG

2007 PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J Biol Chem 282 24514 24524

109. HanEK

LeversonJD

McGonigalT

ShahOJ

WoodsKW

2007 Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Oncogene 26 5655 5661

110. TelemanAA

ChenYW

CohenSM

2005 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes Dev 19 1844 1848

111. HolzMK

BlenisJ

2005 Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J Biol Chem 280 26089 26093

112. RozenS

SkaletskyH

2000 Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132 365 386

113. LeeversSJ

WeinkoveD

MacDougallLK

HafenE

WaterfieldMD

1996 The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. Embo J 15 6584 6594

114. NiJQ

MarksteinM

BinariR

PfeifferB

LiuLP

2008 Vector and parameters for targeted transgenic RNA interference in Drosophila melanogaster. Nat Methods 5 49 51

115. O'BrienKP

RemmM

SonnhammerEL

2005 Inparanoid: a comprehensive database of eukaryotic orthologs. Nucleic Acids Res 33 D476 480

116. WheelerDL

BarrettT

BensonDA

BryantSH

CaneseK

2005 Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 33 Database Issue D39 45

117. KimDH

SarbassovDD

AliSM

LatekRR

GunturKV

2003 GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 11 895 904